St Jude Medical Company Profile (NYSE:STJ)

About St Jude Medical

St Jude Medical logoSt. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: STJ
  • CUSIP: 79084910
Key Metrics:
  • Previous Close: $80.82
  • 50 Day Moving Average: $79.81
  • 200 Day Moving Average: $79.88
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 18.24
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Beta: 1.23
  • Net Margins: 11.05%
  • Return on Equity: 27.02%
  • Return on Assets: 8.99%
  • Debt-to-Equity Ratio: 1.20%
  • Current Ratio: 1.93%
  • Quick Ratio: 1.31%
Additional Links:
Companies Related to St Jude Medical:

Analyst Ratings

Consensus Ratings for St Jude Medical (NYSE:STJ) (?)
Ratings Breakdown: 16 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $76.77 (5.02% downside)

Analysts' Ratings History for St Jude Medical (NYSE:STJ)
DateFirmActionRatingPrice TargetDetails
10/22/2016Barclays PLCReiterated RatingEqual Weight$83.00View Rating Details
10/11/2016Cowen and CompanyReiterated RatingBuy$85.00View Rating Details
9/12/2016Jefferies Group LLCReiterated RatingHold$60.00View Rating Details
8/28/2016ArgusReiterated RatingHoldView Rating Details
8/28/2016Credit Suisse GroupReiterated RatingNeutral$81.00View Rating Details
7/20/2016Canaccord GenuitySet Price TargetHold$85.00View Rating Details
7/21/2016Leerink SwannReiterated RatingHold$85.00View Rating Details
7/17/2016J P Morgan Chase & CoReiterated RatingHoldView Rating Details
7/15/2016WedbushDowngradeOutperform -> Neutral$70.00 -> $84.00View Rating Details
5/10/2016SunTrust Banks, Inc.DowngradeBuy -> Neutral$70.00 -> $80.00View Rating Details
5/2/2016Morgan StanleyDowngradeOverweight -> Equal Weight$67.00 -> $81.00View Rating Details
4/30/2016Wells Fargo & CoReiterated RatingHoldView Rating Details
4/29/2016William BlairDowngradeOutperform -> Market PerformView Rating Details
4/29/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details
4/28/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralView Rating Details
4/18/2016BTIG ResearchDowngradeBuy -> NeutralView Rating Details
4/15/2016Bank of America CorpReiterated RatingBuy$66.00View Rating Details
3/28/2016Oppenheimer Holdings, Inc.Boost Price TargetMarket Perform$57.00 -> $67.00View Rating Details
3/28/2016BMO Capital MarketsBoost Price TargetOutperform$66.00 -> $73.00View Rating Details
3/16/2016NomuraInitiated CoverageBuy$64.00View Rating Details
1/25/2016Royal Bank of CanadaLower Price TargetSector Perform$66.00 -> $57.00View Rating Details
1/15/2016Deutsche Bank AGLower Price TargetHold$65.00 -> $64.00View Rating Details
1/4/2016Sterne Agee CRTLower Price TargetBuy$81.00 -> $78.00View Rating Details
10/22/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details
9/1/2015Evercore ISIReiterated RatingHold$80.00View Rating Details
8/28/2015S&P Equity ResearchReiterated RatingBuy$92.00View Rating Details
(Data available from 2/27/2015 forward)


Earnings History for St Jude Medical (NYSE:STJ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/19/2016Q316$1.01$0.99$1.50 billion$1.50 billionViewListenView Earnings Details
7/20/2016Q216$1.06$1.06$1.55 billion$1.56 billionViewListenView Earnings Details
4/20/2016Q116$0.88$0.90$1.43 billion$1.45 billionViewListenView Earnings Details
1/27/2016Q415$1.01$1.02$1.48 billion$1.45 billionViewListenView Earnings Details
10/21/2015Q315$0.97$0.97$1.35 billion$1.34 billionViewListenView Earnings Details
7/22/2015Q215$1.00$1.03$1.39 billion$1.41 billionViewListenView Earnings Details
4/22/2015Q115$0.91$0.93$1.35 billionViewN/AView Earnings Details
1/28/2015Q414$1.03$1.03$1.44 billion$1.44 billionViewN/AView Earnings Details
10/15/2014Q314$0.96$0.97$1.39 billion$1.38 billionViewListenView Earnings Details
7/16/2014Q214$1.00$1.02$1.44 billion$1.45 billionViewN/AView Earnings Details
4/16/2014Q114$0.95$0.96$1.36 million$1.36 millionViewN/AView Earnings Details
1/22/2014Q413$0.97$0.99$1.38 billion$1.42 billionViewListenView Earnings Details
10/16/2013Q313$0.89$0.90$1.32 billion$1.34 billionViewListenView Earnings Details
7/17/2013Q2 2013$0.94$0.96$1.36 billion$1.40 billionViewListenView Earnings Details
4/17/2013Q1 2013$0.91$0.92$1.36 billion$1.34 billionViewListenView Earnings Details
1/23/2013Q4 2012$0.87$0.92$1.37 billion$1.37 billionViewListenView Earnings Details
10/17/2012$0.81$0.83ViewN/AView Earnings Details
7/18/2012$0.87$0.86ViewN/AView Earnings Details
4/18/2012$0.83$0.86ViewN/AView Earnings Details
1/25/2012$0.84$0.86ViewN/AView Earnings Details
10/19/2011$0.76$0.78ViewN/AView Earnings Details
7/20/2011$0.84$0.85ViewN/AView Earnings Details
4/20/2011$0.78$0.80ViewN/AView Earnings Details
1/26/2011$0.74$0.75ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for St Jude Medical (NYSE:STJ)
Current Year EPS Consensus Estimate: $4.02 EPS
Next Year EPS Consensus Estimate: $4.43 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$0.88$1.04$0.92
Q2 20167$0.99$1.13$1.05
Q3 20166$0.98$1.03$1.01
Q4 20167$1.03$1.12$1.07
Q1 20175$0.98$1.02$1.00
Q2 20175$1.12$1.17$1.14
Q3 20176$1.08$1.16$1.12
Q4 20175$1.14$1.26$1.18
Q1 20182$1.07$1.09$1.08
Q2 20182$1.22$1.30$1.26
Q3 20182$1.17$1.23$1.20
(Data provided by Zacks Investment Research)


Current Dividend Information for St Jude Medical (NYSE:STJ)
Annual Dividend:$1.24
Dividend Yield:1.53%
Dividend Growth:7.60% (3 Year Average)
Payout Ratio:54.39% (Based on Trailing 12 Months of Earnings)
30.85% (Based on Current Year Consensus EPS Estimate)
27.99% (Based on Next Year Consensus EPS Estimate)
Track Record:6 Years of Consecutive Dividend Growth

Dividend History for St Jude Medical (NYSE:STJ)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for St Jude Medical (NYSE:STJ)
Insider Ownership Percentage: 4.80%
Institutional Ownership Percentage: 82.73%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/5/2016Jeff FechoVPSell10,408$51.71$538,197.68View SEC Filing  
12/21/2015Donald ZurbayCFOSell3,106$60.96$189,341.76View SEC Filing  
12/21/2015Jeff DallagerVPSell501$60.94$30,530.94View SEC Filing  
12/18/2015John C HeinmillerEVPSell8,009$61.16$489,830.44View SEC Filing  
10/28/2015Daniel J. StarksCEOSell120,000$62.36$7,483,200.00View SEC Filing  
4/28/2015Daniel J StarksCEOSell100,000$72.46$7,246,000.00View SEC Filing  
4/27/2015Mark W MurphyVPSell5,882$72.45$426,150.90View SEC Filing  
4/24/2015Jason ZellersVPSell3,566$74.13$264,347.58View SEC Filing  
4/24/2015Joel BeckerInsiderSell17,870$73.87$1,320,056.90View SEC Filing  
4/24/2015John C HeinmillerEVPSell160,000$73.69$11,790,400.00View SEC Filing  
4/24/2015Lisa AndradeCMOSell5,000$73.87$369,350.00View SEC Filing  
4/24/2015Stuart EssigDirectorSell7,750$73.85$572,337.50View SEC Filing  
4/22/2015I Paul BaeVPSell34,000$73.00$2,482,000.00View SEC Filing  
4/22/2015Lisa AndradeCMOSell5,000$70.55$352,750.00View SEC Filing  
2/10/2015Michael A RoccaDirectorSell3,875$65.57$254,083.75View SEC Filing  
2/6/2015Michael T RousseauCOOSell7,207$67.31$485,103.17View SEC Filing  
2/3/2015Denis M GestinInsiderSell148,500$67.13$9,968,805.00View SEC Filing  
2/3/2015Scott ThomeVPSell6,666$67.94$452,888.04View SEC Filing  
2/2/2015Mark W MurphyVPSell859$66.92$57,484.28View SEC Filing  
2/2/2015Richard R DevenutiDirectorSell7,750$66.43$514,832.50View SEC Filing  
12/18/2014John C HeinmillerEVPSell6,853$64.60$442,703.80View SEC Filing  
10/27/2014Jeff FechoVPSell500$60.55$30,275.00View SEC Filing  
10/23/2014Jason ZellersVPSell33,999$60.04$2,041,299.96View SEC Filing  
10/22/2014Daniel J StarksCEOSell100,000$60.04$6,004,000.00View SEC Filing  
7/30/2014Mark CarlsonVPSell1,198$66.40$79,547.20View SEC Filing  
7/29/2014Daniel J StarksCEOSell90,000$66.25$5,962,500.00View SEC Filing  
7/29/2014Mark W MurphyVPSell2,000$66.43$132,860.00View SEC Filing  
7/28/2014Denis M GestinInsiderSell99,000$66.76$6,609,240.00View SEC Filing  
7/28/2014Rachel EllingsonVPSell2,630$66.72$175,473.60View SEC Filing  
7/18/2014Scott ThomeVPSell5,997$67.06$402,158.82View SEC Filing  
2/6/2014Michael RoccaDirectorSell5,600$60.36$338,016.00View SEC Filing  
2/5/2014Scott ThomeVPSell7,500$59.57$446,775.00View SEC Filing  
2/4/2014Michael RousseauCOOSell4,644$59.76$277,525.44View SEC Filing  
1/27/2014Jeff FechoVPSell10,408$61.28$637,802.24View SEC Filing  
1/27/2014Joel BeckerInsiderSell14,164$61.58$872,219.12View SEC Filing  
1/24/2014Mark MurphyVPSell9,480$63.14$598,567.20View SEC Filing  
12/18/2013Joel BeckerInsiderSell37,916$59.54$2,257,518.64View SEC Filing  
12/18/2013John HeinmillerEVPSell4,144$59.49$246,526.56View SEC Filing  
12/16/2013Frank CallaghanInsiderSell73,826$59.28$4,376,405.28View SEC Filing  
12/9/2013Daniel StarksCEOSell108,000$59.41$6,416,280.00View SEC Filing  
11/5/2013Daniel StarksCEOSell108,000$57.33$6,191,640.00View SEC Filing  
10/31/2013Michael T RousseauInsiderSell50,000$57.81$2,890,500.00View SEC Filing  
10/29/2013Kathy ChesterVPSell9,375$58.12$544,875.00View SEC Filing  
10/29/2013Michael T RousseauInsiderSell50,000$57.76$2,888,000.00View SEC Filing  
10/28/2013Donald ZurbayCFOSell40,000$57.31$2,292,400.00View SEC Filing  
10/28/2013Mark W MurphyVPSell5,024$57.51$288,930.24View SEC Filing  
10/25/2013Jason ZellersVPSell14,917$57.15$852,506.55View SEC Filing  
10/24/2013Joel BeckerInsiderSell9,613$56.48$542,942.24View SEC Filing  
10/23/2013John C HeinmillerEVPSell150,000$56.48$8,472,000.00View SEC Filing  
10/23/2013Kathy ChesterVPSell20,000$56.50$1,130,000.00View SEC Filing  
10/22/2013Angela D CraigVPSell24,402$56.59$1,380,909.18View SEC Filing  
10/21/2013Frank J CallaghanInsiderSell133,096$56.26$7,487,980.96View SEC Filing  
10/21/2013Mark W MurphyVPSell3,930$56.26$221,101.80View SEC Filing  
10/18/2013Jason ZellersVPSell10,916$56.56$617,408.96View SEC Filing  
10/18/2013Michael T RousseauInsiderSell61,000$56.65$3,455,650.00View SEC Filing  
10/18/2013Wendy L YarnoDirectorSell22,150$56.50$1,251,475.00View SEC Filing  
10/4/2013Denis GestinInsiderSell137,000$55.25$7,569,250.00View SEC Filing  
10/4/2013Donald ZurbayCFOSell12,000$55.55$666,600.00View SEC Filing  
9/11/2013Mark MurphyVPSell4,200$53.50$224,700.00View SEC Filing  
8/9/2013Angela CraigVPSell13,600$54.00$734,400.00View SEC Filing  
8/9/2013Frank CallaghanInsiderSell11,000$54.00$594,000.00View SEC Filing  
7/29/2013Jason ZellersVPSell10,359$52.22$540,946.98View SEC Filing  
7/29/2013Stuart EssigDirectorSell5,600$52.19$292,264.00View SEC Filing  
7/25/2013Kathy ChesterVPSell16,250$52.00$845,000.00View SEC Filing  
7/22/2013Jason ZellersVPSell7,341$51.91$381,071.31View SEC Filing  
7/19/2013Donald ZurbayCFOSell50,000$51.28$2,564,000.00View SEC Filing  
7/19/2013Jeff FechoVPSell13,848$50.82$703,755.36View SEC Filing  
7/19/2013Joel BeckerInsiderSell11,700$50.50$590,850.00View SEC Filing  
5/2/2013Richard R DevenutiDirectorSell5,270$40.64$214,172.80View SEC Filing  
2/5/2013Denis M GestinInsiderSell90,000$41.32$3,718,800.00View SEC Filing  
2/5/2013Thomas R NorthenscoldVPSell22,000$41.40$910,800.00View SEC Filing  
10/25/2012John W BrownDirectorBuy25,000$38.65$966,250.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for St Jude Medical (NYSE:STJ)
DateHeadline logoBRIEF-FTC approves final order settling charges for Abbott's deal with St. Jude Medical (NYSE:STJ) - February 23 at 8:15 PM
News IconFTC Approves Final Order Preserving Competition in U.S. Markets for Medical Devices Used in Cardiac and Vascular Catheterization (NYSE:STJ) - February 23 at 8:15 PM logoSt. Jude Children's Research Hospital® Thanks And Giving Raises $107 Million For The Research And Treatment Of Childhood Cancer (NYSE:STJ) - February 23 at 8:15 PM logoAbbott Laboratories -- Moody's assigns Baa3 to Abbott's proposed exchange notes (NYSE:STJ) - February 23 at 8:15 PM logoAbbott launches exchange offer for $3.1B in St. Jude debt (NYSE:STJ) - February 21 at 4:54 PM logoForm 425 ST JUDE MEDICAL, LLC Filed by: ABBOTT LABORATORIES (NYSE:STJ) - February 21 at 4:54 PM
News IconAbbott floats bid to exchange St. Jude senior notes (NYSE:STJ) - February 21 at 4:54 PM
News IconAnalysts Watch St. Jude Medical, Inc. (NYSE:STJ) And Issue New Targets - NewsDen (NYSE:STJ) - February 20 at 7:08 PM logoUbs Oconnor Llc Buys St Jude Medical, Gulfport Energy, Molson Coors Brewing Co, Sells Ingram ... (NYSE:STJ) - February 18 at 8:53 AM
News IconCole Swindell, Maddie + Tae and More Get Real About Cancer for St. Jude (NYSE:STJ) - February 16 at 7:48 PM logoNanomedical Devices Industry - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2027 (NYSE:STJ) - February 14 at 1:52 AM logoPublicly Traded Merger Arbitrage Funds' Top 10 Holdings Q4 2016 - Seeking Alpha (NYSE:STJ) - February 13 at 12:58 AM
News IconUS Food and Drug Administration, FDA, St. Jude Medical Inc. (NYSE:STJ) - February 12 at 7:56 PM
News Icon$129,000 donated from listeners for St. Jude Kids (NYSE:STJ) - February 11 at 3:53 AM
News IconDHS Issues Update on St. Jude Medical Device Vulnerability (NYSE:STJ) - February 10 at 5:16 AM
News IconSt. Jude Patches Additional Cardiac Device (NYSE:STJ) - February 9 at 5:27 AM
News IconSt. Jude Medical admits new cardiac device flaws discovered, issues patch update (NYSE:STJ) - February 9 at 5:27 AM logoMedSec Provides A Timely Update On Abbott, St. Jude - Benzinga (NYSE:STJ) - February 8 at 6:22 AM logoFDA Approves Abbott Labs' Devices for MRI Scans - Yahoo Finance (NYSE:STJ) - February 3 at 6:02 AM logoFDA Approves Abbott Labs' Devices for MRI Scans - Yahoo Finance - Yahoo Finance (NYSE:STJ) - February 3 at 6:02 AM logoNew Study: St. Jude Medical, Inc. - Strategy, SWOT and Corporate Finance Report (NYSE:STJ) - February 2 at 4:57 AM
News IconSt. Jude Medical MRI-safe pacemaker gets long awaited FDA approval (NYSE:STJ) - February 2 at 4:57 AM
News IconAs St Jude Medical INC (STJ) Market Value Rose, Holder Lmr Partners Llp Cut Position by $3.95 Million (NYSE:STJ) - February 2 at 4:57 AM
News IconEarnings Parade Rolls On, What Are Analysts Saying About St. Jude Medical, Inc. (NYSE:STJ)? - Wall Street Beacon (NYSE:STJ) - February 1 at 6:39 AM
News IconSt Jude Medical INC (STJ) Shareholder Lmr Partners Llp Lowered Its Stake as Stock Rose (NYSE:STJ) - January 30 at 10:24 PM
News IconAre Analysts Predicting a Near-Term Upswing For St. Jude Medical, Inc. (NYSE:STJ)? - Wall Street Beacon (NYSE:STJ) - January 29 at 9:48 PM logo[$$] Abbott Set for 12% EPS Growth (NYSE:STJ) - January 28 at 8:07 PM logoSt Jude Medical : Patent Issued for Magnetically Guided Catheters (USPTO 9545498) (NYSE:STJ) - January 28 at 6:44 AM logoSt Jude Medical : Patent Issued for Staged Deployment Devices and Methods for Transcatheter Heart Valve Delivery Systems (USPTO 9545308) (NYSE:STJ) - January 27 at 5:20 AM
News IconAbbott Laboratories Q4 Profit Climbs 3.9% (NYSE:STJ) - January 26 at 6:06 AM
News IconAbbott CEO field familiar questions about newly acquired St. Jude (NYSE:STJ) - January 26 at 6:06 AM
News IconAbbott touts BurstDR neuromod tech from St. Jude (NYSE:STJ) - January 26 at 6:06 AM
News IconTerumo Completes Acquisition of Certain Abbott and St. Jude Medical Assets (NYSE:STJ) - January 26 at 6:06 AM logoAbbott pauses on deals, to focus on St. Jude integration (NYSE:STJ) - January 26 at 6:06 AM
News IconPerella Weinberg Partners Capital Management LP Has Increased St Jude Med INC (STJ) Holding as Market Valuation ... - The Randolph Guide (NYSE:STJ) - January 25 at 6:15 AM
News IconEarnings in Full Force, Analysts Take Aim at St. Jude Medical, Inc. (NYSE:STJ) - Wall Street Beacon (NYSE:STJ) - January 25 at 6:15 AM
News IconSt Jude case highlights ongoing divide over ‘responsible bugs disclosure’ (NYSE:STJ) - January 23 at 10:31 PM
News IconGearing Up For a Bull Run? Analysts Weigh in on St. Jude Medical, Inc. (NYSE:STJ) - Wall Street Beacon (NYSE:STJ) - January 22 at 6:47 AM
News IconSt. Jude Medical Patches Cardiac Machine's Cybersecurity Flaw (NYSE:STJ) - January 12 at 11:00 PM
News IconBug Uncovered in St. Jude Medical Pacemakers, Defibrillators (NYSE:STJ) - January 11 at 2:26 AM
News IconSt. Jude Medical releases security patches for vulnerable cardiac devices (NYSE:STJ) - January 11 at 2:26 AM
News IconHigh Market Cap Stock of the Day – St. Jude Medical, Inc. (NYSE:STJ) (NYSE:STJ) - January 11 at 2:26 AM
News IconSt. Jude Medical Announces Cybersecurity Updates – Business Wire (press release) (NYSE:STJ) - January 10 at 4:46 AM
News IconFDA confirms St. Jude heart monitors can be hacked, Abbott Labs to release patch (NYSE:STJ) - January 10 at 4:46 AM
News IconCybersecurity Vulnerabilities Identified in St. Jude Medical's Implantable Cardiac Devices and Merlin@home Transmitter: FDA Safety Communication (NYSE:STJ) - January 9 at 11:45 PM
News IconAbbott Completes Acquisition of St. Jude Medical (NYSE:STJ) - January 9 at 11:45 PM
News IconFDA Confirms St. Jude Medical Heart Devices Can be Hacked (NYSE:STJ) - January 9 at 11:45 PM logoSt. Jude Heart Devices Get Cyber Security Updates After Probe Into Hack Vulnerability (NYSE:STJ) - January 9 at 11:45 PM
News IconStock-tanking in St. Jude Medical security disclosure might have legs (NYSE:STJ) - January 9 at 11:45 PM logoSt. Jude Medical Announces Cybersecurity Updates (NYSE:STJ) - January 9 at 11:45 PM


What is St Jude Medical's stock symbol?

St Jude Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "STJ."

How often does St Jude Medical pay dividends? What is the dividend yield for St Jude Medical?

St Jude Medical declared a quarterly dividend on Friday, December 9th. Investors of record on Friday, January 13th will be given a dividend of $0.31 per share on Tuesday, January 31st. This represents a $1.24 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date of this dividend is Wednesday, January 11th.

Where is St Jude Medical's stock going? Where will St Jude Medical's stock price be in 2017?

20 equities research analysts have issued 12-month price objectives for St Jude Medical's shares. Their predictions range from $60.00 to $85.00. On average, they expect St Jude Medical's stock price to reach $76.77 in the next twelve months.

When will St Jude Medical announce their earnings?

St Jude Medical is scheduled to release their next quarterly earnings announcement on Wednesday, January, 25th 2017.

Who owns St Jude Medical stock?

St Jude Medical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (0.00%), Franklin Resources Inc. (0.00%), Davidson Kempner Capital Management LP (0.00%), FMR LLC (0.00%), Eton Park Capital Management L.P. (0.00%) and CNH Partners LLC (0.00%). Company insiders that own St Jude Medical stock include Daniel J Starks, Donald Zurbay, I Paul Bae, Jason Zellers, Jeff Dallager, Jeff Fecho, Joel Becker, John C Heinmiller, Lisa Andrade, Mark W Murphy and Stuart Essig.

Who sold St Jude Medical stock? Who is selling St Jude Medical stock?

St Jude Medical's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Marshall Wace LLP, Alpine Associates Management Inc., Vertex One Asset Management Inc., Angelo Gordon & CO. L.P., Quinn Opportunity Partners LLC, Credit Agricole S A and Public Sector Pension Investment Board.

Who bought St Jude Medical stock? Who is buying St Jude Medical stock?

St Jude Medical's stock was acquired by a variety of institutional investors in the last quarter, including Eton Park Capital Management L.P., Davidson Kempner Capital Management LP, Renaissance Technologies LLC, Alyeska Investment Group L.P., Tudor Investment Corp Et Al, Pentwater Capital Management LP, State Street Corp and FNY Partners Fund LP.

How do I buy St Jude Medical stock?

Shares of St Jude Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of St Jude Medical stock cost?

One share of St Jude Medical stock can currently be purchased for approximately $80.82.

St Jude Medical (NYSE:STJ) Chart for Monday, February, 27, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for St Jude Medical (NYSE:STJ)

Earnings History Chart

Earnings by Quarter for St Jude Medical (NYSE:STJ)

Dividend History Chart

Dividend Payments by Quarter for St Jude Medical (NYSE:STJ)

Last Updated on 2/27/2017 by Staff